Literature DB >> 33446924

Gut priming with bovine colostrum and T regulatory cells in preterm neonates: a randomized controlled trial.

Rania I H Ismail1, Hisham A Awad1, Safaa S Imam1, Ghada I Gad1, Nancy M Aboushady1, Rania M Abdou1, Deena S Eissa2, Nesmahar T Azzam1, Maha M Barakat3, Mostafa M Yassin3, Noha M Barakat4.   

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) and neonatal sepsis are still considered major problems, especially in formula-fed preterm neonates. This study aimed to investigate the effect of bovine colostrum on T regulatory cells, NEC, and late-onset sepsis in preterm neonates ≤34 weeks.
METHODS: This prospective double-blind randomized controlled trial was conducted on 80 preterm infants who were randomly assigned to either the bovine colostrum group (n = 32) or control group (n = 48). T lymphocytes and their subsets, necrotizing enterocolitis, late-onset sepsis (LOS) and its severity, feeding tolerance, growth, length of hospital stay, and mortality were documented.
RESULTS: The bovine colostrum group showed higher follow-up levels of CD4+CD25+ FOXP3+ T lymphocyte % (FOXP3 Tregs). FOXP3 Tregs and its difference in change levels between baseline and follow-up were considered as the most related factors to the bovine colostrum. Bovine colostrum group showed positive trends for reduction of sepsis severity and mortality with no significant difference in the incidence of NEC, LOS, and length of hospital stay.
CONCLUSIONS: Preterm neonates who received bovine colostrum showed a higher FOXP3 Treg level. IMPACT: Bovine colostrum has no significant effect on the incidence of necrotizing enterocolitis. FOXP3 T regulatory cells and their increased level between baseline and follow-up is considered as the most influencing factors related to the bovine colostrum. Positive trends were noted for reduction of sepsis severity and concomitant mortality, but the study lacked the power to assess these outcomes.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33446924     DOI: 10.1038/s41390-020-01344-y

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care.

Authors:  D K Richardson; J E Gray; M C McCormick; K Workman; D A Goldmann
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

2.  Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry.

Authors:  E O Akanni; A Palini
Journal:  EJIFCC       Date:  2006-03-20
  2 in total
  3 in total

Review 1.  Diverse Immune Effects of Bovine Colostrum and Benefits in Human Health and Disease.

Authors:  Subrata Ghosh; Marietta Iacucci
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

Review 2.  Potential Benefits of Bovine Colostrum in Pediatric Nutrition and Health.

Authors:  Per Torp Sangild; Caitlin Vonderohe; Valeria Melendez Hebib; Douglas G Burrin
Journal:  Nutrients       Date:  2021-07-26       Impact factor: 5.717

Review 3.  Insights into the Research Trends on Bovine Colostrum: Beneficial Health Perspectives with Special Reference to Manufacturing of Functional Foods and Feed Supplements.

Authors:  Rahul Mehra; Renu Garhwal; Karnam Sangwan; Raquel P F Guiné; Edite Teixeira Lemos; Harpal Singh Buttar; Pradeep Kumar Singh Visen; Naveen Kumar; Anuradha Bhardwaj; Harish Kumar
Journal:  Nutrients       Date:  2022-02-04       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.